e-Therapeutics (ETX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

9.78p
   
  • Change Today:
    -0.100p
  • 52 Week High: 23.10
  • 52 Week Low: 8.13
  • Currency: UK Pounds
  • Shares Issued: 584.34m
  • Volume: 3,084,089
  • Market Cap: £57.12m
Select chart: 1 week | 1 month
 

1 month

Forecasts

Forecasts data is not available for this company.

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

Trends & Recommendations information not available for this company.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 3: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 4: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

e-Therapeutics Market Data

Currency UK Pounds
Share Price 9.78p
Change Today -0.100p
% Change -1.01 %
52 Week High 23.10
52 Week Low 8.13
Volume 3,084,089
Shares Issued 584.34m
Market Cap £57.12m

e-Therapeutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
22.84% below the market average22.84% below the market average22.84% below the market average22.84% below the market average22.84% below the market average
64.71% above the sector average64.71% above the sector average64.71% above the sector average64.71% above the sector average64.71% above the sector average
Price Trend
38.98% below the market average38.98% below the market average38.98% below the market average38.98% below the market average38.98% below the market average
34.55% above the sector average34.55% above the sector average34.55% above the sector average34.55% above the sector average34.55% above the sector average
Income Not Available
Growth
16.48% below the market average16.48% below the market average16.48% below the market average16.48% below the market average16.48% below the market average
25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average

e-Therapeutics Dividends

No dividends found

Trades for 01-May-2024

Time Volume / Share Price
16:37 300,000 @ 9.92p
16:25 400,000 @ 9.50p
16:27 257,900 @ 9.75p
16:27 100 @ 9.75p
16:27 42,000 @ 9.75p

e-Therapeutics Key Personnel

Chair Trevor Mervyn Jones
CEO Ali Mortazavi

Top of Page